Top compounds associated with response to TNFRSF10C


Feature Type Standardized
Nominal ANOVA
mRNA AS601245 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.03
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.08 0.03
mRNA TAE684 CCLE pan-cancer AAC 0.095 0.03
mRNA Erlotinib gCSI pan-cancer AAC 0.12 0.03
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.091 0.03
mRNA PIK-93 GDSC1000 pan-cancer AAC -0.06 0.03
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.068 0.03
mRNA azacitidine CTRPv2 pan-cancer AAC 0.077 0.04
Download CSV